GSK tests epilepsy med in ALS; Court denies Amgen again over Neupogen biosimilar;

@FiercePharma: GlaxoSmithKline to close Pittsburgh office, consolidate consumer ops in New Jersey. News | Follow @FiercePharma

@EricPFierce: Sanofi Pasteur is adding a fill/finish facility at US site as part of dengue vax plan. More from FiercePharmaManufacturing | Follow @EricPFierce

@CarlyHFierce: ICYMI yesterday: AbbVie moves closer to Japan's crowded hep C field with priority review nod. Article | Follow @CarlyHFierce

> GlaxoSmithKline ($GSK), the ALS Association, the Harvard Stem Cell Institute and Massachusetts General Hospital Neurological Clinical Research Institute are teaming up to investigate Glaxo's epilepsy med retigabine in ALS. More

> The U.S. District Court for the Northern District of California has denied a motion from Amgen ($AMGN) for a preliminary injunction pending appeal that would delay the launch of Novartis' ($NVS) Neupogen biosimilar, Zarxio. More

> Shanghai Fosun Pharmaceutical Group rose to a record in Hong Kong trading after saying it would raise as much as 5.8 billion yuan ($936 million) by selling shares. More

> North Carolina's Quantum Pharma has announced the acquisition of Lamda Limited, Lamda Laboratories SA and Lamda Pharmaceuticals SA for a total consideration of €9.7 million. Report

> The Florida House has OK'ed a "Right to Try" bill that would let patients near death try experimental drugs that are not yet been approved by the FDA. More

> The use of e-cigarettes is rising sharply among teenagers, according to a new report. More (sub. req.)

Medical Device News

@FierceMedDev: ICYMI: PatientsLikeMe and Biogen reveal positive data from wearable device study for MS. Report | Follow @FierceMedDev

@VarunSaxena2: Alcon intraocular lens gets FDA's stringent PMA approval. News | Follow @VarunSaxena2

@EmilyWFierce: Focus Diagnostics gets FDA nod for rapid strep test. FierceDiagnostics article | Follow @EmilyWFierce

> EndoGastric skips toward positive study review for GERD device. More

> Q1 med tech venture dips to lowest since 2013--but med tech IPOs outpace biotech. Report

Biotech News

@FierceBiotech: EuroBiotech Report: Israel awaits $250M fund, ThromboGenics spins out oncology asset, MolMed licenses CAR-T. More | Follow @FierceBiotech

@JohnCFierce: Trending: The flimsy case for a miracle ALS drug collapses under expert scrutiny. Editor's corner | Follow @JohnCFierce

> AstraZeneca's '$3B' lung cancer drug impresses in a Phase II race with Clovis. More

> The FDA calls on Genervon to release data from controversial ALS study. Story

> Atlas Venture unveils a $280M pure play biotech startup fund. Report

And Finally... Could maple syrup help to reduce antibiotic use? More

Suggested Articles

Merck’s Keytruda went up against chemo in a head-to-head colorectal cancer battle—and won.

While the FDA gave an emergency green light to chloroquine's use against coronavirus, European regulators are restricting the drug to clinical trials.

Biocon has finally satisfied the FDA that its insulin production plant in Malaysia is ready for prime time.